Invest Like the Best with Patrick O’Shaughnessy
Business:Investing
My guest today is Alex Telford. Alex is the founder of Convoke, a software platform to help streamline drug development and commercialization. He also has been writing frequent blog posts on the biotech industry since 2019, keeping a pulse on the direction of innovation. He joined me today to talk about the history of the pharmaceutical industry and what’s becoming possible in medicine in the coming years. Alex helped break down the complexities of investing in new drug development, breakthroughs in gene therapy on the horizon, and the dance between timely progress and restrictive regulation. This industry has a lot to unpack, and he thoughtfully lays out the landscape. Please enjoy my conversation with Alex Telford.
Listen to Founders Podcast
For the full show notes, transcript, and links to mentioned content, check out the episode page here.
-----
This episode is brought to you by Tegus, the modern research platform for leading investors. Stretch your research budget with flexible expert calls you can trust. At a fraction of the cost of traditional expert networks, Tegus customers pay only what an expert charges – with zero markups and no confusing call credits – netting an average 70% savings. Don’t want to conduct a full hour call? Tegus offers the ability to schedule 30-minutes, an offer you won’t find anywhere else. And they don’t stop there. With white-glove custom sourcing for every project and robust compliance measures, including a dedicated 50+ analyst team that vets every call transcript, Tegus ensures your privacy and protection. As the industry innovator for qualitative insights, Tegus helps you find the right experts you need at a quality and speed that can’t be matched. For a limited time, as a listener, you can trial Tegus for free by visiting tegus.co/patrick.
-----
Invest Like the Best is a property of Colossus, LLC. For more episodes of Invest Like the Best, visit joincolossus.com/episodes.
Past guests include Tobi Lutke, Kevin Systrom, Mike Krieger, John Collison, Kat Cole, Marc Andreessen, Matthew Ball, Bill Gurley, Anu Hariharan, Ben Thompson, and many more.
Stay up to date on all our podcasts by signing up to Colossus Weekly, our quick dive every Sunday highlighting the top business and investing concepts from our podcasts and the best of what we read that week. Sign up here.
Follow us on Twitter: @patrick_oshag | @JoinColossus
Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com).
Show Notes:
(00:00:00) Welcome to Invest Like the Best
(00:04:01) First question - Exploring public perceptions of Big Pharma
(00:04:56) Providing an overview of the drug discovery process
(00:07:22) Assessing the efficiency of the pharmaceutical industry
(00:12:13) Anticipating the future direction of drug development
(00:16:46) Categorizing different types of pharmaceutical drugs
(00:21:19) Strategies to reduce the time from discovery to implementation
(00:25:55) Gaining insights from cross-disciplinary research
(00:31:13) The emerging role of AI in pharmaceuticals
(00:34:32) Analyzing potential regulatory shifts in the industry
(00:39:13) Discussing the importance of Randomized Controlled Trials (RCTs)
(00:43:29) Examining the impact of blockbuster drugs
(00:47:47) Deliberating on the complexities of drug pricing
(00:54:09) Highlighting exciting developments and concerns in pharma
(00:59:55) The kindest thing anyone has ever done for him
Gaurav Kapadia - Everything Compounds - [Invest Like the Best, EP. 269]
Marko Papic - A Multi-Polar World - [Invest Like the Best, EP. 268]
Garry Tan - Unwrapping the Gift - [Invest Like the Best, EP. 267]
Eric Mandelblatt - Investing in the Industrial Economy - [Invest Like the Best, EP. 266]
Sebastian Kanovich - Powering Emerging Markets Payments - [Founder’s Field Guide, EP. 56]
Frank Slootman - Narrow the Focus, Increase the Quality - [Invest Like the Best, EP. 265]
Tim Flannery - Simplifying Fund Closing - [Founder’s Field Guide, EP. 55]
Joey Levin - Building an Anti-Conglomerate - [Invest Like the Best, EP. 264]
Peter Chernin - Betting on Passion - [Invest Like the Best, EP. 263]
John Pfeffer - Adapt and Evolve - [Invest Like the Best, EP. 262]
Geoffrey Moore - Building Gorilla Businesses - [Invest Like the Best, EP. 261]
Gavin Baker - The Cyclone Under the Surface - [Invest Like the Best, EP. 260]
Sam Englebardt and Richard Kim - Investing in Immersive Worlds - [Invest Like the Best, EP. 259]
Ricky Sandler - Building an Investment Compass - [Invest Like the Best, EP. 258]
Orlando Bravo - The Art of Software Buyouts - [Invest Like the Best, EP. 257]
Nick Saltarelli - One Foot in Front of the Other - [Founder’s Field Guide, EP. 54]
Jenny Johnson - Seven Decades of Investing Expertise - [Invest Like the Best, EP. 256]
Doug Colkitt - The Evolution of Markets - [Invest Like the Best, EP. 255]
Bill Gurley and Philip Rosedale - Back to the Future - [Invest Like the Best, EP. 254]
Francis Davidson - Design-led Hospitality - [Invest Like the Best, EP.253]
Create your
podcast in
minutes
It is Free